NCT05817617 Vitamin D and Head and Neck Cancer: Impact on Toxicity and Prognosis
| NCT ID | NCT05817617 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centro di Riferimento Oncologico - Aviano |
| Condition | Head and Neck Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 953 participants |
| Start Date | 2021-08-08 |
| Primary Completion | 2024-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 953 participants in total. It began in 2021-08-08 with a primary completion date of 2024-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about relation between vitamin D levels in subjects with head and neck cancer. The main question it aims to answer are: * variation of vitamin D levels in the study population at different time points * relation between therapy side effects and vitamin D level * relation between disease outcome and vitamin D level Participants will be followed as per clinical practice
Eligibility Criteria
Inclusion Criteria: histologically proven HNSCC (squamous cell carcinomas), all subsites * non-metastatic locally advanced stages * patients candidate for radical or adjuvant radiotherapy * patients candidate for bilateral neck irradiation * written informed consent Exclusion Criteria: * distant metastases * patients with known disorders of calcium/vitamin D metabolism
Contact & Investigator
Giuseppe Fanetti, MD
PRINCIPAL INVESTIGATOR
Centro di Riferimento Oncologico (CRO), IRCCS
Frequently Asked Questions
Who can join the NCT05817617 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Head and Neck Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05817617 currently recruiting?
Yes, NCT05817617 is actively recruiting participants. Contact the research team at giuseppe.fanetti@cro.it for enrollment information.
Where is the NCT05817617 trial being conducted?
This trial is being conducted at Barletta, Italy, Aviano, Italy, Mestre, Italy, Ancona, Italy and 6 additional locations.
Who is sponsoring the NCT05817617 clinical trial?
NCT05817617 is sponsored by Centro di Riferimento Oncologico - Aviano. The principal investigator is Giuseppe Fanetti, MD at Centro di Riferimento Oncologico (CRO), IRCCS. The trial plans to enroll 953 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.